Charles River Laboratories Overview

  • Founded
  • 1947

Founded
  • Status
  • Public

  • Employees
  • 20,000

Employees
  • Stock Symbol
  • CRL

Stock Symbol
  • Investments
  • 56

  • Share Price
  • $226.52

  • (As of Wednesday Closing)

Charles River Laboratories General Information

Description

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Contact Information

Website
www.criver.com
Formerly Known As
Charles River Foundation, Charles River Breeding Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Stock Exchange
NYS
Primary Office
  • 251 Ballardvale Street
  • Wilmington, MA 01887
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Charles River Laboratories Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$226.52 $214.48 $203.37 - $460.21 $10.9B 50.9M 496K $8.77

Charles River Laboratories Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 14,296,684 22,009,156 14,400,964 9,380,543
Revenue 3,688,047 3,540,160 2,923,933 2,621,226
EBITDA 869,895 819,508 767,637 561,539
Net Income 443,347 390,982 364,304 252,019
Total Assets 7,529,361 7,024,292 5,490,831 4,692,790
Total Debt 3,414,297 2,952,598 2,160,054 2,024,820
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Charles River Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Charles River Laboratories‘s full profile, request access.

Request a free trial

Charles River Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The
Drug Discovery
Wilmington, MA
20,000 As of 2021
00000
00000000000 00000

000000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000 000000000
Ann Arbor, MI
00000 As of 0000
0000000 0000

000000

. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
0000 000000000
Hyderabad, India
0000 As of 0000
0000
00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Charles River Laboratories Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Covance Private Equity-Backed Ann Arbor, MI 00000 0000000 0000
000000 Private Equity-Backed Hyderabad, India 0000 0000 00000000000 0000
000000000 Private Equity-Backed Montreal, Canada 000 000000000000
0000 000000 Formerly PE-Backed Shanghai, China 00000 00.000 000000000 00.000
0000000-000000 Private Equity-Backed San Diego, CA 0000 000000000000
You’re viewing 5 of 10 competitors. Get the full list »

Charles River Laboratories Patents

Charles River Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11129890-B1 Non-integrating hiv-1 comprising mutant rt/in proteins and the sars-cov-2 spike protein Active 19-May-2020 000000000
EP-3999648-A1 Recombinantly-modified adeno-associated virus (raav) having improved packaging efficiency Pending 15-Jul-2019 000000000
AU-2020315513-A1 Recombinantly-modified adeno-associated virus (raav) having improved packaging efficiency Pending 15-Jul-2019 000000000
US-10653731-B1 Recombinantly-modified adeno-associated virus (raav) having improved packaging efficiency Active 15-Jul-2019 0000000000
EP-3999633-A1 Use of ion concentrations to increase the packaging efficiency of recombinant adeno-associated virus Pending 15-Jul-2019 C12N15/86
To view Charles River Laboratories’s complete patent history, request access »

Charles River Laboratories Executive Team (50)

Name Title Board Seat Contact Info
James Foster JD Chief Executive Officer & Chairman
Flavia Pease Chief Financial Officer, Finance & Executive Vice President
Birgit Girshick Chief Operating Officer, Operations
John Ho MD Corporate Senior Vice President, Corporate Strategy & Chief Strategy Officer
Stephen Speirs Chief Technology Officer
You’re viewing 5 of 50 executive team members. Get the full list »

Charles River Laboratories Board Members (16)

Name Representing Role Since
0. 00000 Charles River Laboratories Board Member 000 0000
0000000 00000000 00.0 Charles River Laboratories Board Member 000 0000
000000 00000 Charles River Laboratories Board Member 000 0000
000000 0000000 Charles River Laboratories Board Member 000 0000
00000 000000 00 Charles River Laboratories Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Charles River Laboratories Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Charles River Laboratories Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Charles River Laboratories‘s full profile, request access.

Request a free trial

Charles River Laboratories Investments & Acquisitions (56)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 19-May-2022 00000 0000 000.00 Decision/Risk Analysis
000000 000000 10-May-2022 00000 0000 0000 Drug Discovery
0000000 00000 06-Apr-2022 0000000000 00000 BPO/Outsource Services 00000 000
000.000 31-Dec-2021 00000 0000 00000 Drug Discovery
PathoQuest 09-Nov-2021 Later Stage VC 000.00 Biotechnology
You’re viewing 5 of 56 investments and acquisitions. Get the full list »

Charles River Laboratories Subsidiaries (9)

Company Name Industry Location Founded
Vigene Biosciences Other Pharmaceuticals and Biotechnology Rockville, MD 2012
00000000000 000 Biotechnology South San Francisco, CA 0000
0000000000 Discovery Tools (Healthcare) Chinley, United Kingdom 0000
00000000 Biotechnology Worcester, MA 0000
0000000 0000000 BPO/Outsource Services San Diego, CA 0000
You’re viewing 5 of 9 subsidiaries. Get the full list »

Charles River Laboratories Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 00000 0000 30-Oct-2006 000000000000000000 000.00 Completed
  • 0000000 00000 0000
Charles River Proteomic Services 02-Oct-2002 Joint Venture 000 Completed
  • 2 buyers
To view Charles River Laboratories’s complete exits history, request access »